HealthQuill Dialysis
The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious kidney diseases.
Drugs Health Pharma

FDA approves Apellis’ therapy to treat two serious, rare kidney diseases

HQ Team July 30, 2025: The US Food and Drug Administration has approved Apellis Pharmaceuticals, Inc.’s medicine for treating two rare and serious.

Read More
US surgeons have performed the world’s first successful human bladder transplant on a 41-year-old patient who lost most of his bladder during a tumour removal process.
Drugs Health Medical

Surgeons in US perform world’s first human bladder transplant on a man

HQ Team May 19, 2025: US surgeons have performed the world’s first successful human bladder transplant on a 41-year-old patient who lost most.

Read More
overuse of cannabis can result in impaired memory
Drugs Health Pharma

FDA clears Akebia’s drug to treat anaemia in acute kidney disease

HQ Team March 28, 2024: Akebia Therapeutics, a US Massachusetts-based biotechnology company, has got the regulator’s approval for its Vafseo drug to treat anaemia.

Read More
GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease in patients who have been on dialysis for four months.
Drugs Medical Pharma

GSK Plc gets FDA nod to make oral drug for anaemic CKD patients

GSK Plc., a British global pharmaceutical company, announced the FDA had approved an oral drug to treat anaemia arising from chronic kidney disease.

Read More